Epigenetically programmed identity crisis to combat diffuse large B cell lymphoma

A substantial fraction of patients with diffuse large B cell lymphoma (DLBCL) does not respond to standard-of-care immunochemotherapy.B cell differentiation is intimately associated with defined changes of the epigenetic landscape.DLBCL relies on epigenetic regulators to preserve their proproliferat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trends in immunology
Hauptverfasser: Niccolai, Rachele, Göbel, Camiel, Jacobs, Heinz
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Elsevier Ltd 07.11.2025
Schlagworte:
B cell differentiation
cell identity
diffuse large B cell lymphoma
epigenetics
germinal center
cell identity
germinal center
B cell differentiation
diffuse large B cell lymphoma
epigenetics
ISSN:1471-4906, 1471-4981, 1471-4981
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract A substantial fraction of patients with diffuse large B cell lymphoma (DLBCL) does not respond to standard-of-care immunochemotherapy.B cell differentiation is intimately associated with defined changes of the epigenetic landscape.DLBCL relies on epigenetic regulators to preserve their proproliferative and differentiation-arrested cell identity.Targeting epigenetic regulators has proved effective in unlocking the differentiation arrest of normal as well as malignant B cells. Transcriptional and epigenetic dysregulations during B cell differentiation can lead to diffuse large B cell lymphoma development by locking cells in a proliferative and antiapoptotic state. Understanding how these regulators sustain tumor cell identity is essential for new therapeutic strategies. This review introduces the epigenetically programmed identity crisis strategy, which leverages epigenetic drugs to destabilize tumor cell identity and forces them into nonviable states. A comprehensive understanding of normal germinal center B cell differentiation is essential for deciphering the mechanisms underlying malignant transformation. Germinal center B cell–like diffuse large B cell lymphoma (GCB-DLBCL) originates from the malignant transformation of germinal center B cells. This process is driven by transcriptional and epigenetic dysregulations, frequently caused by recurrent mutations and chromosomal translocations. These changes lead to a differentiation arrest associated with unchecked proliferation and survival. This review highlights key transcriptional and epigenetic dependencies that sustain the GCB-DLBCL phenotype and identifies therapeutic vulnerabilities. Epigenetic targeting of these vulnerabilities unlocks tumor cells from their differentiation arrest, enabling further yet incomplete differentiation toward an antiproliferative, proapoptotic plasma cell–like or memory B cell–like state. We define this transition as an epigenetically programmed identity crisis, a promising therapeutic strategy to target GCB-DLBCL and potentially other malignancies. Germinal center B cell–like diffuse large B cell lymphoma (GCB-DLBCL) originates from the malignant transformation of germinal center B cells. This process is driven by transcriptional and epigenetic dysregulations, frequently caused by recurrent mutations and chromosomal translocations. These changes lead to a differentiation arrest associated with unchecked proliferation and survival. This review highlights key transcriptional and epigenetic dependencies that sustain the GCB-DLBCL phenotype and identifies therapeutic vulnerabilities. Epigenetic targeting of these vulnerabilities unlocks tumor cells from their differentiation arrest, enabling further yet incomplete differentiation toward an antiproliferative, proapoptotic plasma cell–like or memory B cell–like state. We define this transition as an epigenetically programmed identity crisis, a promising therapeutic strategy to target GCB-DLBCL and potentially other malignancies.
AbstractList A substantial fraction of patients with diffuse large B cell lymphoma (DLBCL) does not respond to standard-of-care immunochemotherapy.B cell differentiation is intimately associated with defined changes of the epigenetic landscape.DLBCL relies on epigenetic regulators to preserve their proproliferative and differentiation-arrested cell identity.Targeting epigenetic regulators has proved effective in unlocking the differentiation arrest of normal as well as malignant B cells. Transcriptional and epigenetic dysregulations during B cell differentiation can lead to diffuse large B cell lymphoma development by locking cells in a proliferative and antiapoptotic state. Understanding how these regulators sustain tumor cell identity is essential for new therapeutic strategies. This review introduces the epigenetically programmed identity crisis strategy, which leverages epigenetic drugs to destabilize tumor cell identity and forces them into nonviable states. A comprehensive understanding of normal germinal center B cell differentiation is essential for deciphering the mechanisms underlying malignant transformation. Germinal center B cell–like diffuse large B cell lymphoma (GCB-DLBCL) originates from the malignant transformation of germinal center B cells. This process is driven by transcriptional and epigenetic dysregulations, frequently caused by recurrent mutations and chromosomal translocations. These changes lead to a differentiation arrest associated with unchecked proliferation and survival. This review highlights key transcriptional and epigenetic dependencies that sustain the GCB-DLBCL phenotype and identifies therapeutic vulnerabilities. Epigenetic targeting of these vulnerabilities unlocks tumor cells from their differentiation arrest, enabling further yet incomplete differentiation toward an antiproliferative, proapoptotic plasma cell–like or memory B cell–like state. We define this transition as an epigenetically programmed identity crisis, a promising therapeutic strategy to target GCB-DLBCL and potentially other malignancies. Germinal center B cell–like diffuse large B cell lymphoma (GCB-DLBCL) originates from the malignant transformation of germinal center B cells. This process is driven by transcriptional and epigenetic dysregulations, frequently caused by recurrent mutations and chromosomal translocations. These changes lead to a differentiation arrest associated with unchecked proliferation and survival. This review highlights key transcriptional and epigenetic dependencies that sustain the GCB-DLBCL phenotype and identifies therapeutic vulnerabilities. Epigenetic targeting of these vulnerabilities unlocks tumor cells from their differentiation arrest, enabling further yet incomplete differentiation toward an antiproliferative, proapoptotic plasma cell–like or memory B cell–like state. We define this transition as an epigenetically programmed identity crisis, a promising therapeutic strategy to target GCB-DLBCL and potentially other malignancies.
Germinal center B cell-like diffuse large B cell lymphoma (GCB-DLBCL) originates from the malignant transformation of germinal center B cells. This process is driven by transcriptional and epigenetic dysregulations, frequently caused by recurrent mutations and chromosomal translocations. These changes lead to a differentiation arrest associated with unchecked proliferation and survival. This review highlights key transcriptional and epigenetic dependencies that sustain the GCB-DLBCL phenotype and identifies therapeutic vulnerabilities. Epigenetic targeting of these vulnerabilities unlocks tumor cells from their differentiation arrest, enabling further yet incomplete differentiation toward an antiproliferative, proapoptotic plasma cell-like or memory B cell-like state. We define this transition as an epigenetically programmed identity crisis, a promising therapeutic strategy to target GCB-DLBCL and potentially other malignancies.
Germinal center B cell-like diffuse large B cell lymphoma (GCB-DLBCL) originates from the malignant transformation of germinal center B cells. This process is driven by transcriptional and epigenetic dysregulations, frequently caused by recurrent mutations and chromosomal translocations. These changes lead to a differentiation arrest associated with unchecked proliferation and survival. This review highlights key transcriptional and epigenetic dependencies that sustain the GCB-DLBCL phenotype and identifies therapeutic vulnerabilities. Epigenetic targeting of these vulnerabilities unlocks tumor cells from their differentiation arrest, enabling further yet incomplete differentiation toward an antiproliferative, proapoptotic plasma cell-like or memory B cell-like state. We define this transition as an epigenetically programmed identity crisis, a promising therapeutic strategy to target GCB-DLBCL and potentially other malignancies.Germinal center B cell-like diffuse large B cell lymphoma (GCB-DLBCL) originates from the malignant transformation of germinal center B cells. This process is driven by transcriptional and epigenetic dysregulations, frequently caused by recurrent mutations and chromosomal translocations. These changes lead to a differentiation arrest associated with unchecked proliferation and survival. This review highlights key transcriptional and epigenetic dependencies that sustain the GCB-DLBCL phenotype and identifies therapeutic vulnerabilities. Epigenetic targeting of these vulnerabilities unlocks tumor cells from their differentiation arrest, enabling further yet incomplete differentiation toward an antiproliferative, proapoptotic plasma cell-like or memory B cell-like state. We define this transition as an epigenetically programmed identity crisis, a promising therapeutic strategy to target GCB-DLBCL and potentially other malignancies.
Author Göbel, Camiel
Jacobs, Heinz
Niccolai, Rachele
Author_xml – sequence: 1
  givenname: Rachele
  surname: Niccolai
  fullname: Niccolai, Rachele
  organization: Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands
– sequence: 2
  givenname: Camiel
  surname: Göbel
  fullname: Göbel, Camiel
  organization: Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands
– sequence: 3
  givenname: Heinz
  orcidid: 0000-0001-6227-9850
  surname: Jacobs
  fullname: Jacobs, Heinz
  email: h.jacobs@nki.nl
  organization: Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/41206331$$D View this record in MEDLINE/PubMed
BookMark eNp9kTlPwzAYhi1URA_YmZBHlgQ7lx02qMohVUJI3S3H-VJccmG7SPn3OCp0YOjkQ89jvd_rOZq0XQsIXVMSUkKzu12oXRiRKPXHkBB2hmY0YTRIck4nxz3Jpmhu7Y4QmjLGLtA0oRHJ4pjO0Puq11towWkl63rAvem2RjYNlFiX0DrtBqyMttpi12HVNYV0uNRVtbeAa2m2gB-xgrrG9dD0H10jL9F5JWsLV7_rAm2eVpvlS7B-e35dPqwDFVPKgrjIFEujPIWiqpI0LiglMueFSiTPk1JynigfM0tLxhWPZZQXkazKnFEAnqXxAt0envWJv_ZgnWi0HYPIFrq9FXHECMlTzplHb37RfeEHE73RjTSD-GvBA-QAKNNZa6A6IpSIsWixE9qJsejxxhftlfuDAn7Ebw1GWKWhVVBqA8qJstOnZP5PVrVuxx_4hOG0-gPxRZbA
Cites_doi 10.3389/fimmu.2014.00103
10.1038/s41590-018-0273-1
10.1038/nature10351
10.1038/ng.518
10.1038/ni.2428
10.4049/jimmunol.1800952
10.15252/embr.201438793
10.1016/j.ccell.2024.02.010
10.1182/blood-2010-04-280149
10.1038/nrd.2017.111
10.1038/ni1454
10.1016/j.ccell.2020.04.004
10.1146/annurev-biochem-051710-134100
10.1016/j.immuni.2019.08.006
10.1111/imr.13016
10.1016/S0092-8674(00)00078-7
10.1158/2159-8290.CD-16-0975
10.1038/nature09730
10.1038/nri2217
10.1172/JCI70626
10.1182/blood-2017-03-769620
10.1073/pnas.0437996100
10.1016/j.immuni.2016.09.001
10.1182/blood-2010-04-189977
10.1038/ncomms5273
10.1038/nm.3799
10.1038/nature03147
10.1073/pnas.1602025113
10.1146/annurev-immunol-020711-075027
10.1016/j.ccell.2024.02.011
10.1126/science.1062589
10.1182/blood-2013-04-496893
10.1016/S0092-8674(02)00759-6
10.1016/j.cell.2017.09.027
10.1016/j.immuni.2021.07.015
10.3324/haematol.2020.274258
10.1038/s41467-020-15884-8
10.15252/embr.202051184
10.1056/NEJMoa1708566
10.1158/2159-8290.CD-19-0116
10.1056/NEJMoa1801445
10.1158/2159-8290.CD-21-1059
10.1182/blood-2017-11-764332
10.1038/nri953
10.1016/j.tips.2014.01.001
10.3389/fimmu.2021.705848
10.1038/cmi.2017.133
10.1016/j.immuni.2009.01.011
10.1038/nm.3940
10.1111/imr.12755
10.1038/35000501
10.1007/s00412-015-0570-5
10.1073/pnas.1732008100
10.1056/NEJMoa1707447
10.1038/sj.onc.1204640
10.1038/s41375-019-0392-1
10.1038/ni.2418
10.3389/fcell.2021.805195
10.1038/s41467-018-07905-4
10.3389/fimmu.2024.1385319
10.4049/jimmunol.1701470
10.1016/j.celrep.2020.108504
10.1073/pnas.2104013118
10.1016/j.coi.2016.12.004
10.1182/blood.2024025500
10.1016/j.immuni.2015.12.004
10.3389/fimmu.2019.00438
10.1182/blood.2019000962
10.1038/ni1245
10.1038/s41375-022-01620-2
10.1038/nm.3943
10.1038/ni.2524
10.1158/2159-8290.CD-16-1417
10.1182/blood-2012-03-415380
10.1016/j.clim.2014.10.002
10.1053/j.seminhematol.2023.11.004
10.1016/j.immuni.2016.01.011
10.1016/j.ccr.2013.04.011
10.1182/blood.2024026534
10.1126/sciadv.1500447
10.1016/j.immuni.2019.07.001
10.1016/S0167-5699(00)01687-X
10.1016/j.ccr.2010.09.006
10.1007/s12032-021-01572-0
10.1053/j.seminhematol.2015.01.005
10.1182/blood-2013-11-536433
10.1038/s41578-020-00269-6
ContentType Journal Article
Copyright 2025 The Author(s)
Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Copyright_xml – notice: 2025 The Author(s)
– notice: Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.it.2025.10.007
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1471-4981
ExternalDocumentID 41206331
10_1016_j_it_2025_10_007
S1471490625002510
Genre Journal Article
Review
GroupedDBID ---
--K
--M
-DZ
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29Q
2KS
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8FE
8FH
8P~
9DU
9M8
AAAJQ
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAMRU
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABEFU
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACLOT
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKEYQ
BKOJK
BLXMC
BPHCQ
BVXVI
CJTIS
CS3
D0L
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IH2
IHE
J1W
KOM
L7B
LK8
LUGTX
M41
MO0
MVM
N9A
O-L
O9-
O9~
OAUVE
OK0
OMK
OZT
P-8
P-9
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSI
SSZ
T5K
WOW
X7M
XPP
Y6R
Z5R
ZCG
ZGI
~G-
~HD
6I.
AAFTH
AAYXX
CITATION
NPM
7X8
ID FETCH-LOGICAL-c3117-3b6c75295ebff453b110a98bc4a894da884c41265d78c83a29b2afd971ee8653
ISSN 1471-4906
1471-4981
IngestDate Mon Nov 10 00:57:31 EST 2025
Mon Nov 10 01:42:43 EST 2025
Thu Nov 27 00:50:01 EST 2025
Sat Nov 29 17:04:19 EST 2025
Sat Nov 29 06:56:29 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords cell identity
germinal center
B cell differentiation
diffuse large B cell lymphoma
epigenetics
Language English
License This is an open access article under the CC BY license.
Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3117-3b6c75295ebff453b110a98bc4a894da884c41265d78c83a29b2afd971ee8653
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0001-6227-9850
OpenAccessLink https://www.clinicalkey.com/#!/content/1-s2.0-S1471490625002510
PMID 41206331
PQID 3270095887
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3270095887
pubmed_primary_41206331
crossref_primary_10_1016_j_it_2025_10_007
elsevier_sciencedirect_doi_10_1016_j_it_2025_10_007
elsevier_clinicalkey_doi_10_1016_j_it_2025_10_007
PublicationCentury 2000
PublicationDate 2025-Nov-07
PublicationDateYYYYMMDD 2025-11-07
PublicationDate_xml – month: 11
  year: 2025
  text: 2025-Nov-07
  day: 07
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Trends in immunology
PublicationTitleAlternate Trends Immunol
PublicationYear 2025
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Young, Brink (bb0005) 2021; 54
Oliva, Cenci (bb0305) 2014; 5
Hanahan (bb0410) 2022; 12
Bitler (bb0390) 2015; 21
Göbel, C.
Kadoch, Crabtree (bb0365) 2015; 1
Meyer (bb0350) 2019; 51
Scheer (bb0425) 2019; 10
Cancro, Tomayko (bb0090) 2021; 303
Morin (bb0235) 2010; 42
Mair (bb0025) 2014; 35
Reddy (bb0190) 2017; 171
Ma (bb0380) 2022; 107
Dominguez-Sola (bb0095) 2012; 13
Li (bb0335) 2014; 5
Pasqualucci, Dalla-Favera (bb0400) 2018; 131
Schmiedel (bb0370) 2021; 12
Velichutina (bb0220) 2010; 116
Kealy (bb0280) 2024; 15
Serganova (bb0405) 2022; 9
Herviou (bb0225) 2019; 33
Barisic (bb0385) 2024; 42
Kealy (bb0270) 2020; 33
Roco (bb0065) 2019; 51
Cobaleda (bb0060) 2007; 8
EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood 122, 3165–3168
Schmitz (bb0205) 2018; 378
Coffey (bb0055) 2009; 30
Alaggio (bb0020) 2022; 36
Weisel (bb0080) 2016; 44
Liu (bb0295) 2021; 38
Calado (bb0100) 2012; 13
Kuè, R. and Dalla-Favera, R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20, 5580–5594
Wang (bb0155) 2023; 60
Van Leeuwen (bb0255) 2002; 109
Klein, Dalla-Favera (bb0040) 2008; 8
Pengo (bb0300) 2013; 14
Pé Rez-Galán (bb0415) 2011; 117
Morin (bb0325) 2011; 476
Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of diffuse large B cell lymphoma. Blood 145, 1802–1813
Wu (bb0050) 2018; 15
Klein (bb0070) 2002; 100
Pasqualucci (bb0355) 2011; 471
Pilzecker, Jacobs (bb0120) 2019; 10
Bannard, Cyster (bb0010) 2017; 45
Grossmann, V.
Béguelin (bb0240) 2020; 37
Victora (bb0175) 2012; 120
Shaffer (bb0195) 2012; 30
Guo (bb0250) 2018; 200
Wang (bb0160) 2014; 155
Muramatsu (bb0110) 2000; 102
Jiang (bb0340) 2017; 7
Scott (bb0125) 2014; 123
Phan (bb0140) 2005; 6
Caganova (bb0245) 2013; 123
Ortega-Molina (bb0320) 2015; 21
Deng (bb0375) 2024; 42
Cheloha (bb0435) 2020; 11
Shilatifard (bb0310) 2012; 81
Fearon (bb0150) 2001; 293
Vlaming, van Leeuwen (bb0265) 2016; 125
Alizadeh (bb0185) 2000; 403
Haines (bb0290) 2018; 201
Béguelin (bb0135) 2013; 23
Mlynarczyk (bb0215) 2019; 288
Mondello (bb0360) 2020; 10
Pasqualucci, Dalla-Favera (bb0210) 2015; 52
Vlaming (bb0260) 2014; 15
Zhang (bb0315) 2015; 21
Ferrari, Peyvandi (bb0330) 2020; 136
Gitlin (bb0075) 2016; 44
Schuster (bb0165) 2017; 377
Wright (bb0180) 2003; 100
Crump (bb0015) 2017; 130
Zhang (bb0345) 2017; 7
Moffat (bb0420) 2017; 16
Duan (bb0275) 2021; 118
Hatzi (bb0285) 2019; 20
Aslam (bb0130) 2021; 22
Neelapu (bb0170) 2017; 377
Wilson (bb0395) 2010; 18
Tarlinton, S.K. (bb0085) 2000; 21
Hogenbirk (bb0115) 2016; 113
Mesin (bb0045) 2016; 45
Phan, Dalla-Favera (bb0105) 2004; 432
Manzari (bb0430) 2021; 6
Shaffer (bb0145) 2002; 2
Thuy (bb0035) 2025; 145
Pilzecker (10.1016/j.it.2025.10.007_bb0120) 2019; 10
Morin (10.1016/j.it.2025.10.007_bb0235) 2010; 42
Vlaming (10.1016/j.it.2025.10.007_bb0265) 2016; 125
Scott (10.1016/j.it.2025.10.007_bb0125) 2014; 123
Duan (10.1016/j.it.2025.10.007_bb0275) 2021; 118
Oliva (10.1016/j.it.2025.10.007_bb0305) 2014; 5
Thuy (10.1016/j.it.2025.10.007_bb0035) 2025; 145
Shaffer (10.1016/j.it.2025.10.007_bb0195) 2012; 30
Mlynarczyk (10.1016/j.it.2025.10.007_bb0215) 2019; 288
Manzari (10.1016/j.it.2025.10.007_bb0430) 2021; 6
Wang (10.1016/j.it.2025.10.007_bb0160) 2014; 155
Coffey (10.1016/j.it.2025.10.007_bb0055) 2009; 30
Serganova (10.1016/j.it.2025.10.007_bb0405) 2022; 9
Kealy (10.1016/j.it.2025.10.007_bb0280) 2024; 15
Bitler (10.1016/j.it.2025.10.007_bb0390) 2015; 21
Alizadeh (10.1016/j.it.2025.10.007_bb0185) 2000; 403
Pasqualucci (10.1016/j.it.2025.10.007_bb0400) 2018; 131
10.1016/j.it.2025.10.007_bb0030
Shaffer (10.1016/j.it.2025.10.007_bb0145) 2002; 2
Vlaming (10.1016/j.it.2025.10.007_bb0260) 2014; 15
Hatzi (10.1016/j.it.2025.10.007_bb0285) 2019; 20
Mondello (10.1016/j.it.2025.10.007_bb0360) 2020; 10
Shilatifard (10.1016/j.it.2025.10.007_bb0310) 2012; 81
Zhang (10.1016/j.it.2025.10.007_bb0315) 2015; 21
Deng (10.1016/j.it.2025.10.007_bb0375) 2024; 42
10.1016/j.it.2025.10.007_bb0230
Ortega-Molina (10.1016/j.it.2025.10.007_bb0320) 2015; 21
Weisel (10.1016/j.it.2025.10.007_bb0080) 2016; 44
Jiang (10.1016/j.it.2025.10.007_bb0340) 2017; 7
Neelapu (10.1016/j.it.2025.10.007_bb0170) 2017; 377
Aslam (10.1016/j.it.2025.10.007_bb0130) 2021; 22
Caganova (10.1016/j.it.2025.10.007_bb0245) 2013; 123
Reddy (10.1016/j.it.2025.10.007_bb0190) 2017; 171
Fearon (10.1016/j.it.2025.10.007_bb0150) 2001; 293
Ma (10.1016/j.it.2025.10.007_bb0380) 2022; 107
Hogenbirk (10.1016/j.it.2025.10.007_bb0115) 2016; 113
Haines (10.1016/j.it.2025.10.007_bb0290) 2018; 201
Wilson (10.1016/j.it.2025.10.007_bb0395) 2010; 18
Tarlinton (10.1016/j.it.2025.10.007_bb0085) 2000; 21
Li (10.1016/j.it.2025.10.007_bb0335) 2014; 5
Herviou (10.1016/j.it.2025.10.007_bb0225) 2019; 33
Moffat (10.1016/j.it.2025.10.007_bb0420) 2017; 16
Gitlin (10.1016/j.it.2025.10.007_bb0075) 2016; 44
Schmiedel (10.1016/j.it.2025.10.007_bb0370) 2021; 12
Wu (10.1016/j.it.2025.10.007_bb0050) 2018; 15
10.1016/j.it.2025.10.007_bb0200
Hanahan (10.1016/j.it.2025.10.007_bb0410) 2022; 12
Velichutina (10.1016/j.it.2025.10.007_bb0220) 2010; 116
Wang (10.1016/j.it.2025.10.007_bb0155) 2023; 60
Wright (10.1016/j.it.2025.10.007_bb0180) 2003; 100
Kealy (10.1016/j.it.2025.10.007_bb0270) 2020; 33
Klein (10.1016/j.it.2025.10.007_bb0040) 2008; 8
Liu (10.1016/j.it.2025.10.007_bb0295) 2021; 38
Pasqualucci (10.1016/j.it.2025.10.007_bb0210) 2015; 52
Ferrari (10.1016/j.it.2025.10.007_bb0330) 2020; 136
Mair (10.1016/j.it.2025.10.007_bb0025) 2014; 35
Roco (10.1016/j.it.2025.10.007_bb0065) 2019; 51
Meyer (10.1016/j.it.2025.10.007_bb0350) 2019; 51
Cobaleda (10.1016/j.it.2025.10.007_bb0060) 2007; 8
Pengo (10.1016/j.it.2025.10.007_bb0300) 2013; 14
Scheer (10.1016/j.it.2025.10.007_bb0425) 2019; 10
Cancro (10.1016/j.it.2025.10.007_bb0090) 2021; 303
Morin (10.1016/j.it.2025.10.007_bb0325) 2011; 476
Zhang (10.1016/j.it.2025.10.007_bb0345) 2017; 7
Klein (10.1016/j.it.2025.10.007_bb0070) 2002; 100
Calado (10.1016/j.it.2025.10.007_bb0100) 2012; 13
Phan (10.1016/j.it.2025.10.007_bb0140) 2005; 6
Cheloha (10.1016/j.it.2025.10.007_bb0435) 2020; 11
Victora (10.1016/j.it.2025.10.007_bb0175) 2012; 120
Schuster (10.1016/j.it.2025.10.007_bb0165) 2017; 377
Guo (10.1016/j.it.2025.10.007_bb0250) 2018; 200
Barisic (10.1016/j.it.2025.10.007_bb0385) 2024; 42
Crump (10.1016/j.it.2025.10.007_bb0015) 2017; 130
Schmitz (10.1016/j.it.2025.10.007_bb0205) 2018; 378
Young (10.1016/j.it.2025.10.007_bb0005) 2021; 54
Béguelin (10.1016/j.it.2025.10.007_bb0135) 2013; 23
Phan (10.1016/j.it.2025.10.007_bb0105) 2004; 432
Béguelin (10.1016/j.it.2025.10.007_bb0240) 2020; 37
Kadoch (10.1016/j.it.2025.10.007_bb0365) 2015; 1
Van Leeuwen (10.1016/j.it.2025.10.007_bb0255) 2002; 109
Muramatsu (10.1016/j.it.2025.10.007_bb0110) 2000; 102
Bannard (10.1016/j.it.2025.10.007_bb0010) 2017; 45
Alaggio (10.1016/j.it.2025.10.007_bb0020) 2022; 36
Pasqualucci (10.1016/j.it.2025.10.007_bb0355) 2011; 471
Mesin (10.1016/j.it.2025.10.007_bb0045) 2016; 45
Dominguez-Sola (10.1016/j.it.2025.10.007_bb0095) 2012; 13
Pé Rez-Galán (10.1016/j.it.2025.10.007_bb0415) 2011; 117
References_xml – volume: 42
  start-page: 605
  year: 2024
  end-page: 622.e11
  ident: bb0375
  article-title: SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions
  publication-title: Cancer Cell
– volume: 8
  start-page: 22
  year: 2008
  end-page: 33
  ident: bb0040
  article-title: Germinal centres: role in B-cell physiology and malignancy
  publication-title: Nat. Rev. Immunol.
– volume: 54
  start-page: 1652
  year: 2021
  end-page: 1664
  ident: bb0005
  article-title: The unique biology of germinal center B cells
  publication-title: Immunity
– reference: EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood 122, 3165–3168
– volume: 44
  start-page: 769
  year: 2016
  end-page: 781
  ident: bb0075
  article-title: Independent roles of switching and hypermutation in the development and persistence of B lymphocyte memory
  publication-title: Immunity
– volume: 44
  start-page: 116
  year: 2016
  end-page: 130
  ident: bb0080
  article-title: A temporal switch in the germinal center determines differential output of memory B and plasma cells
  publication-title: Immunity
– volume: 123
  start-page: 1214
  year: 2014
  end-page: 1217
  ident: bb0125
  article-title: Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
  publication-title: Blood
– volume: 123
  start-page: 5009
  year: 2013
  end-page: 5022
  ident: bb0245
  article-title: Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
  publication-title: J. Clin. Invest.
– volume: 7
  start-page: 323
  year: 2017
  end-page: 337
  ident: bb0345
  article-title: The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma
  publication-title: Cancer Discov.
– volume: 145
  start-page: 2873
  year: 2025
  end-page: 2886
  ident: bb0035
  article-title: Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma
  publication-title: Blood
– volume: 45
  start-page: 471
  year: 2016
  end-page: 482
  ident: bb0045
  article-title: Germinal center B cell dynamics
  publication-title: Immunity
– volume: 51
  start-page: 337
  year: 2019
  end-page: 350.e7
  ident: bb0065
  article-title: Class-switch recombination occurs infrequently in germinal centers
  publication-title: Immunity
– volume: 377
  start-page: 2531
  year: 2017
  end-page: 2544
  ident: bb0170
  article-title: Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma
  publication-title: N. Engl. J. Med.
– volume: 35
  start-page: 136
  year: 2014
  end-page: 145
  ident: bb0025
  article-title: Exploiting epigenetic vulnerabilities for cancer therapeutics
  publication-title: Trends Pharmacol. Sci.
– volume: 10
  start-page: 438
  year: 2019
  ident: bb0120
  article-title: Mutating for good: DNA damage responses during somatic hypermutation
  publication-title: Front. Immunol.
– volume: 6
  start-page: 1054
  year: 2005
  end-page: 1060
  ident: bb0140
  article-title: BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells
  publication-title: Nat. Immunol.
– volume: 403
  start-page: 503
  year: 2000
  end-page: 511
  ident: bb0185
  article-title: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
  publication-title: Nature
– volume: 12
  start-page: 31
  year: 2022
  end-page: 46
  ident: bb0410
  article-title: Hallmarks of cancer: new dimensions
  publication-title: Cancer Discov.
– volume: 45
  start-page: 21
  year: 2017
  end-page: 30
  ident: bb0010
  article-title: Germinal centers: programmed for affinity maturation and antibody diversification
  publication-title: Curr. Opin. Immunol.
– volume: 9
  year: 2022
  ident: bb0405
  article-title: Epigenetic, metabolic, and immune crosstalk in germinal-center-derived B-cell lymphomas: unveiling new vulnerabilities for rational combination therapies
  publication-title: Front. Cell. Dev. Biol.
– volume: 6
  start-page: 351
  year: 2021
  end-page: 370
  ident: bb0430
  article-title: Targeted drug delivery strategies for precision medicines
  publication-title: Nat. Rev. Mater.
– volume: 100
  start-page: 9991
  year: 2003
  end-page: 9996
  ident: bb0180
  article-title: A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 51
  start-page: 535
  year: 2019
  end-page: 547.e9
  ident: bb0350
  article-title: Unique and shared epigenetic programs of the CREBBP and EP300 acetyltransferases in germinal center B cells reveal targetable dependencies in lymphoma
  publication-title: Immunity
– volume: 117
  start-page: 26
  year: 2011
  end-page: 38
  ident: bb0415
  article-title: Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
  publication-title: Blood
– volume: 130
  start-page: 1800
  year: 2017
  end-page: 1808
  ident: bb0015
  article-title: Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
  publication-title: Blood
– reference: Kuè, R. and Dalla-Favera, R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20, 5580–5594
– volume: 30
  start-page: 565
  year: 2012
  end-page: 610
  ident: bb0195
  article-title: Pathogenesis of human B cell lymphomas
  publication-title: Annu. Rev. Immunol.
– volume: 21
  start-page: 436
  year: 2000
  end-page: 441
  ident: bb0085
  article-title: Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory B cells in the germinal centre
  publication-title: Immunol. Today
– volume: 155
  start-page: 160
  year: 2014
  end-page: 175
  ident: bb0160
  article-title: Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells
  publication-title: Clin. Immunol.
– volume: 81
  start-page: 65
  year: 2012
  end-page: 95
  ident: bb0310
  article-title: The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis
  publication-title: Annu. Rev. Biochem.
– volume: 5
  start-page: 4273
  year: 2014
  ident: bb0335
  article-title: Shp1 signalling is required to establish the long-lived bone marrow plasma cell pool
  publication-title: Nat. Commun.
– volume: 12
  year: 2021
  ident: bb0370
  article-title: Brg1 supports B cell proliferation and germinal center formation through enhancer activation
  publication-title: Front. Immunol.
– volume: 8
  start-page: 463
  year: 2007
  end-page: 470
  ident: bb0060
  article-title: Pax5: the guardian of B cell identity and function
  publication-title: Nat. Immunol.
– volume: 200
  start-page: 1039
  year: 2018
  end-page: 1052
  ident: bb0250
  article-title: EZH2 represses the B cell transcriptional program and regulates antibody-secreting cell metabolism and antibody production
  publication-title: J. Immunol.
– volume: 14
  start-page: 298
  year: 2013
  end-page: 305
  ident: bb0300
  article-title: Plasma cells require autophagy for sustainable immunoglobulin production
  publication-title: Nat. Immunol.
– volume: 1
  year: 2015
  ident: bb0365
  article-title: Mammalian SWI/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics
  publication-title: Sci. Adv.
– volume: 15
  start-page: 676
  year: 2018
  end-page: 684
  ident: bb0050
  article-title: Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity
  publication-title: Cell. Mol. Immunol.
– volume: 100
  start-page: 2639
  year: 2002
  end-page: 2644
  ident: bb0070
  article-title: Transcriptional analysis of the B cell germinal center reaction
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 38
  start-page: 124
  year: 2021
  ident: bb0295
  article-title: The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy
  publication-title: Med. Oncol.
– volume: 60
  start-page: 255
  year: 2023
  end-page: 266
  ident: bb0155
  article-title: Epidemiology and etiology of diffuse large B-cell lymphoma
  publication-title: Semin. Hematol.
– volume: 131
  start-page: 2307
  year: 2018
  end-page: 2319
  ident: bb0400
  article-title: Genetics of diffuse large B-cell lymphoma
  publication-title: Blood
– volume: 22
  year: 2021
  ident: bb0130
  article-title: Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation
  publication-title: EMBO Rep.
– volume: 20
  start-page: 86
  year: 2019
  end-page: 96
  ident: bb0285
  article-title: Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis
  publication-title: Nat. Immunol.
– reference: Grossmann, V.
– volume: 37
  start-page: 655
  year: 2020
  end-page: 673.e11
  ident: bb0240
  article-title: Mutant EZH2 Induces a pre-malignant lymphoma niche by reprogramming the immune response
  publication-title: Cancer Cell
– volume: 2
  start-page: 920
  year: 2002
  end-page: 932
  ident: bb0145
  article-title: Lymphoid malignancies: the dark side of B-cell differentiation
  publication-title: Nat. Rev. Immunol.
– volume: 118
  year: 2021
  ident: bb0275
  article-title: Role of Dot1L and H3K79 methylation in regulating somatic hypermutation of immunoglobulin genes
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 13
  start-page: 1092
  year: 2012
  end-page: 1100
  ident: bb0100
  article-title: The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers
  publication-title: Nat. Immunol.
– volume: 15
  year: 2024
  ident: bb0280
  article-title: An emerging maestro of immune regulation: how DOT1L orchestrates the harmonies of the immune system
  publication-title: Front. Immunol.
– volume: 21
  start-page: 1199
  year: 2015
  end-page: 1208
  ident: bb0320
  article-title: The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
  publication-title: Nat. Med.
– volume: 136
  start-page: 2125
  year: 2020
  end-page: 2132
  ident: bb0330
  article-title: KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
  publication-title: Blood
– volume: 42
  start-page: 181
  year: 2010
  end-page: 185
  ident: bb0235
  article-title: Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
  publication-title: Nat. Genet.
– volume: 288
  start-page: 214
  year: 2019
  end-page: 239
  ident: bb0215
  article-title: Germinal center-derived lymphomas: the darkest side of humoral immunity
  publication-title: Immunol. Rev.
– volume: 171
  start-page: 481
  year: 2017
  end-page: 494.e15
  ident: bb0190
  article-title: Genetic and functional drivers of diffuse large B cell lymphoma
  publication-title: Cell
– volume: 36
  start-page: 1720
  year: 2022
  end-page: 1748
  ident: bb0020
  article-title: The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
  publication-title: Leukemia
– volume: 15
  start-page: 1077
  year: 2014
  end-page: 1084
  ident: bb0260
  article-title: Flexibility in crosstalk between H2B ubiquitination and H3 methylation in vivo
  publication-title: EMBO Rep.
– volume: 107
  start-page: 690
  year: 2022
  end-page: 701
  ident: bb0380
  article-title: Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
  publication-title: Haematologica
– volume: 476
  start-page: 298
  year: 2011
  end-page: 303
  ident: bb0325
  article-title: Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
  publication-title: Nature
– volume: 16
  start-page: 531
  year: 2017
  end-page: 543
  ident: bb0420
  article-title: Opportunities and challenges in phenotypic drug discovery: an industry perspective
  publication-title: Nat. Rev. Drug Discov.
– volume: 52
  start-page: 67
  year: 2015
  end-page: 76
  ident: bb0210
  article-title: The genetic landscape of diffuse large B-cell lymphoma
  publication-title: Semin. Hematol.
– volume: 432
  start-page: 630
  year: 2004
  end-page: 635
  ident: bb0105
  article-title: The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
  publication-title: Nature
– volume: 42
  start-page: 583
  year: 2024
  end-page: 604.e11
  ident: bb0385
  article-title: ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis
  publication-title: Cancer Cell
– volume: 125
  start-page: 593
  year: 2016
  end-page: 605
  ident: bb0265
  article-title: The upstreams and downstreams of H3K79 methylation by DOT1L
  publication-title: Chromosoma
– volume: 116
  start-page: 5247
  year: 2010
  end-page: 5255
  ident: bb0220
  article-title: EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
  publication-title: Blood
– volume: 378
  start-page: 1396
  year: 2018
  end-page: 1407
  ident: bb0205
  article-title: Genetics and pathogenesis of diffuse large B-cell lymphoma
  publication-title: N. Engl. J. Med.
– volume: 7
  start-page: 38
  year: 2017
  end-page: 53
  ident: bb0340
  article-title: CREBBP inactivation promotes the development of HDAC3-dependent lymphomas
  publication-title: Cancer Discov.
– volume: 293
  start-page: 248
  year: 2001
  end-page: 250
  ident: bb0150
  article-title: Arrested differentiation, the self-renewing memory lymphocyte, and vaccination
  publication-title: Science
– volume: 109
  start-page: 745
  year: 2002
  end-page: 756
  ident: bb0255
  article-title: Dot1p modulates silencing in yeast by methylation of the nucleosome core proteins and with the nucleosomes
  publication-title: Cell
– volume: 21
  start-page: 231
  year: 2015
  end-page: 238
  ident: bb0390
  article-title: Targeting EZH2 methyltransferase activity in ARID1A mutated cancer cells is synthetic lethal
  publication-title: Nat. Med.
– volume: 33
  year: 2020
  ident: bb0270
  article-title: The histone methyltransferase DOT1L is essential for humoral immune responses
  publication-title: Cell Rep.
– volume: 113
  start-page: E3649
  year: 2016
  end-page: E3656
  ident: bb0115
  article-title: Defining chromosomal translocation risks in cancer
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 30
  start-page: 599
  year: 2009
  end-page: 609
  ident: bb0055
  article-title: Initial clonal expansion of germinal center B cells takes place at the perimeter of follicles
  publication-title: Immunity
– reference: Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of diffuse large B cell lymphoma. Blood 145, 1802–1813
– volume: 23
  start-page: 677
  year: 2013
  end-page: 692
  ident: bb0135
  article-title: EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation
  publication-title: Cancer Cell
– volume: 10
  start-page: 440
  year: 2020
  end-page: 459
  ident: bb0360
  article-title: Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma
  publication-title: Cancer Discov.
– reference: Göbel, C.
– volume: 21
  start-page: 1190
  year: 2015
  end-page: 1198
  ident: bb0315
  article-title: Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis
  publication-title: Nat. Med.
– volume: 102
  start-page: 553
  year: 2000
  end-page: 563
  ident: bb0110
  article-title: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme
  publication-title: Cell
– volume: 201
  start-page: 2799
  year: 2018
  end-page: 2811
  ident: bb0290
  article-title: The histone demethylase LSD1 regulates B cell proliferation and plasmablast differentiation
  publication-title: J. Immunol.
– volume: 11
  start-page: 2087
  year: 2020
  ident: bb0435
  article-title: Improved GPCR ligands from nanobody tethering
  publication-title: Nat. Commun.
– volume: 18
  start-page: 316
  year: 2010
  end-page: 328
  ident: bb0395
  article-title: Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation
  publication-title: Cancer Cell
– volume: 10
  start-page: 19
  year: 2019
  ident: bb0425
  article-title: A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
  publication-title: Nat. Commun.
– volume: 33
  start-page: 2047
  year: 2019
  end-page: 2060
  ident: bb0225
  article-title: EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation
  publication-title: Leukemia
– volume: 303
  start-page: 72
  year: 2021
  end-page: 82
  ident: bb0090
  article-title: Memory B cells and plasma cells: the differentiative continuum of humoral immunity
  publication-title: Immunol. Rev.
– volume: 5
  start-page: 103
  year: 2014
  ident: bb0305
  article-title: Autophagy in plasma cell pathophysiology
  publication-title: Front. Immunol.
– volume: 13
  start-page: 1083
  year: 2012
  end-page: 1091
  ident: bb0095
  article-title: The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry
  publication-title: Nat. Immunol.
– volume: 471
  start-page: 189
  year: 2011
  end-page: 196
  ident: bb0355
  article-title: Inactivating mutations of acetyltransferase genes in B-cell lymphoma
  publication-title: Nature
– volume: 377
  start-page: 2545
  year: 2017
  end-page: 2554
  ident: bb0165
  article-title: Chimeric antigen receptor T cells in refractory B-cell lymphomas
  publication-title: N. Engl. J. Med.
– volume: 120
  start-page: 2240
  year: 2012
  end-page: 2248
  ident: bb0175
  article-title: Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas
  publication-title: Blood
– volume: 5
  start-page: 103
  year: 2014
  ident: 10.1016/j.it.2025.10.007_bb0305
  article-title: Autophagy in plasma cell pathophysiology
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2014.00103
– volume: 20
  start-page: 86
  year: 2019
  ident: 10.1016/j.it.2025.10.007_bb0285
  article-title: Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-018-0273-1
– volume: 476
  start-page: 298
  year: 2011
  ident: 10.1016/j.it.2025.10.007_bb0325
  article-title: Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
  publication-title: Nature
  doi: 10.1038/nature10351
– volume: 42
  start-page: 181
  year: 2010
  ident: 10.1016/j.it.2025.10.007_bb0235
  article-title: Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
  publication-title: Nat. Genet.
  doi: 10.1038/ng.518
– volume: 13
  start-page: 1083
  year: 2012
  ident: 10.1016/j.it.2025.10.007_bb0095
  article-title: The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2428
– volume: 201
  start-page: 2799
  year: 2018
  ident: 10.1016/j.it.2025.10.007_bb0290
  article-title: The histone demethylase LSD1 regulates B cell proliferation and plasmablast differentiation
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1800952
– volume: 15
  start-page: 1077
  year: 2014
  ident: 10.1016/j.it.2025.10.007_bb0260
  article-title: Flexibility in crosstalk between H2B ubiquitination and H3 methylation in vivo
  publication-title: EMBO Rep.
  doi: 10.15252/embr.201438793
– volume: 42
  start-page: 583
  year: 2024
  ident: 10.1016/j.it.2025.10.007_bb0385
  article-title: ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2024.02.010
– volume: 116
  start-page: 5247
  year: 2010
  ident: 10.1016/j.it.2025.10.007_bb0220
  article-title: EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
  publication-title: Blood
  doi: 10.1182/blood-2010-04-280149
– volume: 16
  start-page: 531
  year: 2017
  ident: 10.1016/j.it.2025.10.007_bb0420
  article-title: Opportunities and challenges in phenotypic drug discovery: an industry perspective
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd.2017.111
– volume: 8
  start-page: 463
  year: 2007
  ident: 10.1016/j.it.2025.10.007_bb0060
  article-title: Pax5: the guardian of B cell identity and function
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1454
– volume: 37
  start-page: 655
  year: 2020
  ident: 10.1016/j.it.2025.10.007_bb0240
  article-title: Mutant EZH2 Induces a pre-malignant lymphoma niche by reprogramming the immune response
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2020.04.004
– volume: 81
  start-page: 65
  year: 2012
  ident: 10.1016/j.it.2025.10.007_bb0310
  article-title: The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev-biochem-051710-134100
– volume: 51
  start-page: 535
  year: 2019
  ident: 10.1016/j.it.2025.10.007_bb0350
  article-title: Unique and shared epigenetic programs of the CREBBP and EP300 acetyltransferases in germinal center B cells reveal targetable dependencies in lymphoma
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.08.006
– volume: 303
  start-page: 72
  year: 2021
  ident: 10.1016/j.it.2025.10.007_bb0090
  article-title: Memory B cells and plasma cells: the differentiative continuum of humoral immunity
  publication-title: Immunol. Rev.
  doi: 10.1111/imr.13016
– volume: 102
  start-page: 553
  year: 2000
  ident: 10.1016/j.it.2025.10.007_bb0110
  article-title: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)00078-7
– volume: 7
  start-page: 38
  year: 2017
  ident: 10.1016/j.it.2025.10.007_bb0340
  article-title: CREBBP inactivation promotes the development of HDAC3-dependent lymphomas
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-16-0975
– volume: 471
  start-page: 189
  year: 2011
  ident: 10.1016/j.it.2025.10.007_bb0355
  article-title: Inactivating mutations of acetyltransferase genes in B-cell lymphoma
  publication-title: Nature
  doi: 10.1038/nature09730
– volume: 8
  start-page: 22
  year: 2008
  ident: 10.1016/j.it.2025.10.007_bb0040
  article-title: Germinal centres: role in B-cell physiology and malignancy
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2217
– volume: 123
  start-page: 5009
  year: 2013
  ident: 10.1016/j.it.2025.10.007_bb0245
  article-title: Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI70626
– volume: 130
  start-page: 1800
  year: 2017
  ident: 10.1016/j.it.2025.10.007_bb0015
  article-title: Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
  publication-title: Blood
  doi: 10.1182/blood-2017-03-769620
– volume: 100
  start-page: 2639
  year: 2002
  ident: 10.1016/j.it.2025.10.007_bb0070
  article-title: Transcriptional analysis of the B cell germinal center reaction
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0437996100
– volume: 45
  start-page: 471
  year: 2016
  ident: 10.1016/j.it.2025.10.007_bb0045
  article-title: Germinal center B cell dynamics
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.09.001
– volume: 117
  start-page: 26
  year: 2011
  ident: 10.1016/j.it.2025.10.007_bb0415
  article-title: Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
  publication-title: Blood
  doi: 10.1182/blood-2010-04-189977
– volume: 5
  start-page: 4273
  year: 2014
  ident: 10.1016/j.it.2025.10.007_bb0335
  article-title: Shp1 signalling is required to establish the long-lived bone marrow plasma cell pool
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms5273
– volume: 21
  start-page: 231
  year: 2015
  ident: 10.1016/j.it.2025.10.007_bb0390
  article-title: Targeting EZH2 methyltransferase activity in ARID1A mutated cancer cells is synthetic lethal
  publication-title: Nat. Med.
  doi: 10.1038/nm.3799
– volume: 432
  start-page: 630
  year: 2004
  ident: 10.1016/j.it.2025.10.007_bb0105
  article-title: The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
  publication-title: Nature
  doi: 10.1038/nature03147
– volume: 113
  start-page: E3649
  year: 2016
  ident: 10.1016/j.it.2025.10.007_bb0115
  article-title: Defining chromosomal translocation risks in cancer
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1602025113
– volume: 30
  start-page: 565
  year: 2012
  ident: 10.1016/j.it.2025.10.007_bb0195
  article-title: Pathogenesis of human B cell lymphomas
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-020711-075027
– volume: 42
  start-page: 605
  year: 2024
  ident: 10.1016/j.it.2025.10.007_bb0375
  article-title: SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2024.02.011
– volume: 293
  start-page: 248
  year: 2001
  ident: 10.1016/j.it.2025.10.007_bb0150
  article-title: Arrested differentiation, the self-renewing memory lymphocyte, and vaccination
  publication-title: Science
  doi: 10.1126/science.1062589
– ident: 10.1016/j.it.2025.10.007_bb0230
  doi: 10.1182/blood-2013-04-496893
– volume: 109
  start-page: 745
  year: 2002
  ident: 10.1016/j.it.2025.10.007_bb0255
  article-title: Dot1p modulates silencing in yeast by methylation of the nucleosome core proteins and with the nucleosomes
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00759-6
– volume: 171
  start-page: 481
  year: 2017
  ident: 10.1016/j.it.2025.10.007_bb0190
  article-title: Genetic and functional drivers of diffuse large B cell lymphoma
  publication-title: Cell
  doi: 10.1016/j.cell.2017.09.027
– volume: 54
  start-page: 1652
  year: 2021
  ident: 10.1016/j.it.2025.10.007_bb0005
  article-title: The unique biology of germinal center B cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2021.07.015
– volume: 107
  start-page: 690
  year: 2022
  ident: 10.1016/j.it.2025.10.007_bb0380
  article-title: Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
  publication-title: Haematologica
  doi: 10.3324/haematol.2020.274258
– volume: 11
  start-page: 2087
  year: 2020
  ident: 10.1016/j.it.2025.10.007_bb0435
  article-title: Improved GPCR ligands from nanobody tethering
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-15884-8
– volume: 22
  year: 2021
  ident: 10.1016/j.it.2025.10.007_bb0130
  article-title: Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation
  publication-title: EMBO Rep.
  doi: 10.15252/embr.202051184
– volume: 377
  start-page: 2545
  year: 2017
  ident: 10.1016/j.it.2025.10.007_bb0165
  article-title: Chimeric antigen receptor T cells in refractory B-cell lymphomas
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1708566
– volume: 10
  start-page: 440
  year: 2020
  ident: 10.1016/j.it.2025.10.007_bb0360
  article-title: Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-19-0116
– volume: 378
  start-page: 1396
  year: 2018
  ident: 10.1016/j.it.2025.10.007_bb0205
  article-title: Genetics and pathogenesis of diffuse large B-cell lymphoma
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1801445
– volume: 12
  start-page: 31
  year: 2022
  ident: 10.1016/j.it.2025.10.007_bb0410
  article-title: Hallmarks of cancer: new dimensions
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-21-1059
– volume: 131
  start-page: 2307
  year: 2018
  ident: 10.1016/j.it.2025.10.007_bb0400
  article-title: Genetics of diffuse large B-cell lymphoma
  publication-title: Blood
  doi: 10.1182/blood-2017-11-764332
– volume: 2
  start-page: 920
  year: 2002
  ident: 10.1016/j.it.2025.10.007_bb0145
  article-title: Lymphoid malignancies: the dark side of B-cell differentiation
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri953
– volume: 35
  start-page: 136
  year: 2014
  ident: 10.1016/j.it.2025.10.007_bb0025
  article-title: Exploiting epigenetic vulnerabilities for cancer therapeutics
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/j.tips.2014.01.001
– volume: 12
  year: 2021
  ident: 10.1016/j.it.2025.10.007_bb0370
  article-title: Brg1 supports B cell proliferation and germinal center formation through enhancer activation
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2021.705848
– volume: 15
  start-page: 676
  year: 2018
  ident: 10.1016/j.it.2025.10.007_bb0050
  article-title: Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity
  publication-title: Cell. Mol. Immunol.
  doi: 10.1038/cmi.2017.133
– volume: 30
  start-page: 599
  year: 2009
  ident: 10.1016/j.it.2025.10.007_bb0055
  article-title: Initial clonal expansion of germinal center B cells takes place at the perimeter of follicles
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.01.011
– volume: 21
  start-page: 1190
  year: 2015
  ident: 10.1016/j.it.2025.10.007_bb0315
  article-title: Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis
  publication-title: Nat. Med.
  doi: 10.1038/nm.3940
– volume: 288
  start-page: 214
  year: 2019
  ident: 10.1016/j.it.2025.10.007_bb0215
  article-title: Germinal center-derived lymphomas: the darkest side of humoral immunity
  publication-title: Immunol. Rev.
  doi: 10.1111/imr.12755
– volume: 403
  start-page: 503
  year: 2000
  ident: 10.1016/j.it.2025.10.007_bb0185
  article-title: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
  publication-title: Nature
  doi: 10.1038/35000501
– volume: 125
  start-page: 593
  year: 2016
  ident: 10.1016/j.it.2025.10.007_bb0265
  article-title: The upstreams and downstreams of H3K79 methylation by DOT1L
  publication-title: Chromosoma
  doi: 10.1007/s00412-015-0570-5
– volume: 100
  start-page: 9991
  year: 2003
  ident: 10.1016/j.it.2025.10.007_bb0180
  article-title: A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1732008100
– volume: 377
  start-page: 2531
  year: 2017
  ident: 10.1016/j.it.2025.10.007_bb0170
  article-title: Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1707447
– ident: 10.1016/j.it.2025.10.007_bb0200
  doi: 10.1038/sj.onc.1204640
– volume: 33
  start-page: 2047
  year: 2019
  ident: 10.1016/j.it.2025.10.007_bb0225
  article-title: EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation
  publication-title: Leukemia
  doi: 10.1038/s41375-019-0392-1
– volume: 13
  start-page: 1092
  year: 2012
  ident: 10.1016/j.it.2025.10.007_bb0100
  article-title: The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2418
– volume: 9
  year: 2022
  ident: 10.1016/j.it.2025.10.007_bb0405
  article-title: Epigenetic, metabolic, and immune crosstalk in germinal-center-derived B-cell lymphomas: unveiling new vulnerabilities for rational combination therapies
  publication-title: Front. Cell. Dev. Biol.
  doi: 10.3389/fcell.2021.805195
– volume: 10
  start-page: 19
  year: 2019
  ident: 10.1016/j.it.2025.10.007_bb0425
  article-title: A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-07905-4
– volume: 15
  year: 2024
  ident: 10.1016/j.it.2025.10.007_bb0280
  article-title: An emerging maestro of immune regulation: how DOT1L orchestrates the harmonies of the immune system
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2024.1385319
– volume: 200
  start-page: 1039
  year: 2018
  ident: 10.1016/j.it.2025.10.007_bb0250
  article-title: EZH2 represses the B cell transcriptional program and regulates antibody-secreting cell metabolism and antibody production
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1701470
– volume: 33
  year: 2020
  ident: 10.1016/j.it.2025.10.007_bb0270
  article-title: The histone methyltransferase DOT1L is essential for humoral immune responses
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2020.108504
– volume: 118
  year: 2021
  ident: 10.1016/j.it.2025.10.007_bb0275
  article-title: Role of Dot1L and H3K79 methylation in regulating somatic hypermutation of immunoglobulin genes
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.2104013118
– volume: 45
  start-page: 21
  year: 2017
  ident: 10.1016/j.it.2025.10.007_bb0010
  article-title: Germinal centers: programmed for affinity maturation and antibody diversification
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2016.12.004
– ident: 10.1016/j.it.2025.10.007_bb0030
  doi: 10.1182/blood.2024025500
– volume: 44
  start-page: 116
  year: 2016
  ident: 10.1016/j.it.2025.10.007_bb0080
  article-title: A temporal switch in the germinal center determines differential output of memory B and plasma cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.12.004
– volume: 10
  start-page: 438
  year: 2019
  ident: 10.1016/j.it.2025.10.007_bb0120
  article-title: Mutating for good: DNA damage responses during somatic hypermutation
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.00438
– volume: 136
  start-page: 2125
  year: 2020
  ident: 10.1016/j.it.2025.10.007_bb0330
  article-title: KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
  publication-title: Blood
  doi: 10.1182/blood.2019000962
– volume: 6
  start-page: 1054
  year: 2005
  ident: 10.1016/j.it.2025.10.007_bb0140
  article-title: BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1245
– volume: 36
  start-page: 1720
  year: 2022
  ident: 10.1016/j.it.2025.10.007_bb0020
  article-title: The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
  publication-title: Leukemia
  doi: 10.1038/s41375-022-01620-2
– volume: 21
  start-page: 1199
  year: 2015
  ident: 10.1016/j.it.2025.10.007_bb0320
  article-title: The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
  publication-title: Nat. Med.
  doi: 10.1038/nm.3943
– volume: 14
  start-page: 298
  year: 2013
  ident: 10.1016/j.it.2025.10.007_bb0300
  article-title: Plasma cells require autophagy for sustainable immunoglobulin production
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2524
– volume: 7
  start-page: 323
  year: 2017
  ident: 10.1016/j.it.2025.10.007_bb0345
  article-title: The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-16-1417
– volume: 120
  start-page: 2240
  year: 2012
  ident: 10.1016/j.it.2025.10.007_bb0175
  article-title: Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas
  publication-title: Blood
  doi: 10.1182/blood-2012-03-415380
– volume: 155
  start-page: 160
  year: 2014
  ident: 10.1016/j.it.2025.10.007_bb0160
  article-title: Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells
  publication-title: Clin. Immunol.
  doi: 10.1016/j.clim.2014.10.002
– volume: 60
  start-page: 255
  year: 2023
  ident: 10.1016/j.it.2025.10.007_bb0155
  article-title: Epidemiology and etiology of diffuse large B-cell lymphoma
  publication-title: Semin. Hematol.
  doi: 10.1053/j.seminhematol.2023.11.004
– volume: 44
  start-page: 769
  year: 2016
  ident: 10.1016/j.it.2025.10.007_bb0075
  article-title: Independent roles of switching and hypermutation in the development and persistence of B lymphocyte memory
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.01.011
– volume: 23
  start-page: 677
  year: 2013
  ident: 10.1016/j.it.2025.10.007_bb0135
  article-title: EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.04.011
– volume: 145
  start-page: 2873
  year: 2025
  ident: 10.1016/j.it.2025.10.007_bb0035
  article-title: Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma
  publication-title: Blood
  doi: 10.1182/blood.2024026534
– volume: 1
  year: 2015
  ident: 10.1016/j.it.2025.10.007_bb0365
  article-title: Mammalian SWI/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.1500447
– volume: 51
  start-page: 337
  year: 2019
  ident: 10.1016/j.it.2025.10.007_bb0065
  article-title: Class-switch recombination occurs infrequently in germinal centers
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.07.001
– volume: 21
  start-page: 436
  year: 2000
  ident: 10.1016/j.it.2025.10.007_bb0085
  article-title: Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory B cells in the germinal centre
  publication-title: Immunol. Today
  doi: 10.1016/S0167-5699(00)01687-X
– volume: 18
  start-page: 316
  year: 2010
  ident: 10.1016/j.it.2025.10.007_bb0395
  article-title: Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2010.09.006
– volume: 38
  start-page: 124
  year: 2021
  ident: 10.1016/j.it.2025.10.007_bb0295
  article-title: The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy
  publication-title: Med. Oncol.
  doi: 10.1007/s12032-021-01572-0
– volume: 52
  start-page: 67
  year: 2015
  ident: 10.1016/j.it.2025.10.007_bb0210
  article-title: The genetic landscape of diffuse large B-cell lymphoma
  publication-title: Semin. Hematol.
  doi: 10.1053/j.seminhematol.2015.01.005
– volume: 123
  start-page: 1214
  year: 2014
  ident: 10.1016/j.it.2025.10.007_bb0125
  article-title: Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
  publication-title: Blood
  doi: 10.1182/blood-2013-11-536433
– volume: 6
  start-page: 351
  year: 2021
  ident: 10.1016/j.it.2025.10.007_bb0430
  article-title: Targeted drug delivery strategies for precision medicines
  publication-title: Nat. Rev. Mater.
  doi: 10.1038/s41578-020-00269-6
SSID ssj0015777
Score 2.4898648
SecondaryResourceType review_article
online_first
Snippet A substantial fraction of patients with diffuse large B cell lymphoma (DLBCL) does not respond to standard-of-care immunochemotherapy.B cell differentiation is...
Germinal center B cell-like diffuse large B cell lymphoma (GCB-DLBCL) originates from the malignant transformation of germinal center B cells. This process is...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
SubjectTerms B cell differentiation
cell identity
diffuse large B cell lymphoma
epigenetics
germinal center
Title Epigenetically programmed identity crisis to combat diffuse large B cell lymphoma
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1471490625002510
https://dx.doi.org/10.1016/j.it.2025.10.007
https://www.ncbi.nlm.nih.gov/pubmed/41206331
https://www.proquest.com/docview/3270095887
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: ScienceDirect Freedom Collection - Elsevier
  customDbUrl:
  eissn: 1471-4981
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015777
  issn: 1471-4906
  databaseCode: AIEXJ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdru5W-jK37yj6KBnsZxgXbkiU9NiX7KFvZRhh5M5KsgEPqhNoZzf76nSzJbTayj4e9mCBHjnO_4-4k_e4OoVeJFJIYWKnmzPCY5FrEXKcy1kxIYRRnqkuP_vqBnZ_zyUR88p3pmq6dAKtrfnUllv8VahgDsG3q7D_A3T8UBuAzgA5XgB2ufwX8aGkLbLrcRLt14QhY4PSiyiXlriOwFLYOCYSd8AJKtl2blFVjornlhUfDyG7nR_M1IL3wdnvW_kShrWxiycaePCgVaJVrb_3F1ome90rz1p7HD3PlKAGn8qIyPbPjDGyyapwLrOrvN7chUtrl4zlXaZzpBDcXE-EasPximN0ewey4svzVlB53jDp286sgxeVFhwlJUgicvHPYLIYdbu2gvZRRAWZs7-T9aHLWHxxRxpg_jXY0vs0fPED74RHbApFtC40u4BjfQ3f9SgGfOITvo1umPkR3XO_Q9SHa_-hZEQ_Q503I8TXkOECOHeS4XWAHOfaQ4w5yPMQWchwgf4jGb0bj03exb5UR6yyBOCNTuWb2zNao6ZTQTEFUJwVXmkguSCk5Jxr-eE5LxjXPZCpUKqelYIkxPKfZI7RbL2rzBOFSEANrBKkSnZGyhABwSkwiE81KYajWA_Q6iK1YuoIoRWAKzoqqLay07QhIe4CSINciJPqCaypAKX4zJ-vn-CDQBXd_mPUywFaAfbQik7VZrJois8wKQcGXDtBjh2f_3kEVnm698wwdXCv7c7TbXq7MC3Rbf2ur5vII7bAJP_Iq-AMftInM
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epigenetically+programmed+identity+crisis+to+combat+diffuse+large+B+cell+lymphoma&rft.jtitle=Trends+in+immunology&rft.au=Niccolai%2C+Rachele&rft.au=G%C3%B6bel%2C+Camiel&rft.au=Jacobs%2C+Heinz&rft.date=2025-11-07&rft.eissn=1471-4981&rft_id=info:doi/10.1016%2Fj.it.2025.10.007&rft_id=info%3Apmid%2F41206331&rft.externalDocID=41206331
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-4906&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-4906&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-4906&client=summon